Xenon Pharmaceuticals Inc (FRA:XP0)
€ 37.4 0 (0%) Market Cap: 2.84 Bil Enterprise Value: 2.20 Bil PE Ratio: 0 PB Ratio: 3.45 GF Score: 49/100

Full Year 2018 Xenon Pharmaceuticals Inc Earnings Call Transcript

Mar 06, 2019 / 09:30PM GMT
Release Date Price: €7.5 (-1.57%)
Operator

Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2018 Xenon Pharmaceuticals Inc. Financial Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference, Jodi Regts. Ma'am, you may begin.

Jodi Regts
Xenon Pharmaceuticals Inc. - VP of Corporate Affairs & IR

Thanks, Heather. Good afternoon. Thank you for joining us on our call and webcast to discuss our 2018 financial and operating results.

Joining me on today's call are Dr. Simon Pimstone, Xenon's Chief Executive Officer; and Ian Mortimer, Xenon's President and Chief Financial Officer. Following this introduction, Simon will provide perspective on Xenon's progress, and then Ian will review our financial results. After that, we will open up the call to your questions.

Please be advised that during this call, we will make a number of statements that are forward-looking, including statements about the sufficiency of our cash to fund operations into 2021; the timing of IND

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot